The Source for CFO Thought Leadership

biotech

934: You’ll Figure It Out | Svai Sanford, CFO, Rani Therapeutics

We are near the end of our discussion with CFO Svai Sanford when he permits us to unlock one last door to his past. Unbeknownst to us, 20 minutes earlier, Sanford had handed us the key to its lock in the form of a short story. The story had begun with Sanford receiving a job…
Listen to the Episode Below (0:57:28)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

920: When Leadership Calls | Erin Colgan, CFO, Sensei Bio

For many professionals, the period stretching roughly from March 2020 to December 2022 will forever be known simply as “COVID," as in “I changed jobs during COVID.” Thus it was for Erin Colgan, who in July 2020—after having invested 9 years within the finance rank-and-file of pharma giant Vertex Pharmaceuticals and 8 years with PWC—opted…
Listen to the Episode Below (0:30:39)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

Why the Journey Matters | Galit Yaakobovitz, CFO, AmyriAD

CFO GUEST: Galit Yaakobovitz of AmyriAD Yaakobovitz: I think it’s also a part of my personality. Uh, I like the journey, and I’ll tell you about my personal life later, but, uh, I, I like to enjoy the journey. And if I’m, uh, in a certain path and I enjoy it, I don’t really care […]

887: From Tech to Biotech: Enjoying Today’s Journey | Galit Yaakobovitz, CFO, AmyriAD

After Galit Yaakobovitz relocated from Israel to the United States back in the mid-2000s, there was little question that the move had given her career a boost. Still, it was the next relocation—the one that would move her and her husband from New Jersey to California—that ultimately allowed her to place both feet on a…
Listen to the Episode Below (00:55:44)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

882: The Chronic Door Opener | Brianna Gerber, CFO, ChromaDex

When Brianna Gerber tells us that during earnings season at Mattel, Inc., she was once known as the investor relations person most likely to be “knocking on doors,” we can’t help but want to learn more about her IR tour of duty at the toy giant.   “I’d be calling on the marketing team and…
Listen to the Episode Below (00:47:39)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

802: Making an Industry Lane Change | Mike Catelani, CFO, Anixa Biosciences, Inc.

When Mike Catelani seeks to identify the objectives and career milestones that have helped to advance him into the ranks of Bay Area biotech CFOs, he mentions that although he had a deep interest in biology during his high school years, upon entering college he decided to swap out a biology curriculum for an accounting…
Listen to the Episode Below (00:53:31)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

796: Gene Editing’s Next Frontier | Elaine Sun, CFO, Mammoth Biosciences

Having grown accustomed to charting the careers of our finance leader guests from their early professional days up through their entry into the CFO office, we did not change course for Elaine Sun, an accomplished investment banker turned finance leader who last month stepped into her third successive finance chief position at Mammoth Biosciences of…
Listen to the Episode Below (00:47:34)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

782: When Operations Came First | Lou Arcudi, CFO, Amolyt Pharma

To those well familiar with the career milestones that typically mark the path to the CFO office, Lou Arcudi’s resume at first may appear to be upside down. Or at least it could be said that the same operational projects and roles that frequently populate the tops of the resumes of aspiring CFOs are instead…
Listen to the Episode Below (01:08:41)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

745: Origins of a Comeback Therapy | Troy Ignelzi, CFO, Karuna Therapeutics

"You can achieve greatness and success no matter how humble your beginnings. Always give the best that you can contribute based on your skill set and surround yourself with the right people." –Troy Ignelzi, CFO, Karuna Therapeutics Troy Ignelzi’s CFO career is rooted in an unlikely place. In fact, some might describe it as the…
Listen to the Episode Below (00:45:24)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

699: The Return of Jimmy Lai | Jimmy Lai, CFO, Acepodia

When Acepodia CEO Sonny Hsiao began developing a list of candidates to fill the chief financial officer role at the biotechnology company that he had cofounded, it may have surprised some to see Jimmy Lai make the list. Certainly, this was not due to any U.S. markets void on Lai’s resume—to the contrary, he had…
Listen to the Episode Below (00:40:10)
1x
0:00
00:40:10
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn

689: Be the Bridge | Terry Coelho, CFO, BioDelivery Sciences International (BDSI)

Within 4 months of her 2019 arrival inside BDSI’s CFO office, Terry Coelho had spearheaded a product acquisition and managed a successful equity raise—two finance milestones that would produce generous sales tailwinds for the specialty pharmaceutical firm.   BDSI would experience 100% net sales growth in 2019, followed by 40% net sales growth in 2020. …
Listen to the Episode Below (00:49:00)
Apple PodcastsGoogle PodcastsPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyWhere to ListenYoutubeLinkedInLinkedIn